UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
December 15, 2022 4:00 P.M.
Form:
F-3
CIK:
0001783036
Company Name:
NLS Pharmaceutics Ltd.
File Number:
333-268690